IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
To replicate, viruses must gain access to the host cell's resources. Interferon (IFN) regulates the actions of a large complement of interferon effector genes (IEGs) that prevent viral replication. The interferon inducible transmembrane protein family members, IFITM1, 2 and 3, are IEGs required for inhibition of influenza A virus, dengue virus, and West Nile virus replication in vitro. Here we report that IFN prevents emergence of viral genomes from the endosomal pathway, and that IFITM3 is both necessary and sufficient for this function. Notably, viral pseudoparticles were inhibited from transferring their contents into the host cell cytosol by IFN, and IFITM3 was required and sufficient for this action. We further demonstrate that IFN expands Rab7 and LAMP1-containing structures, and that IFITM3 overexpression is sufficient for this phenotype. Moreover, IFITM3 partially resides in late endosomal and lysosomal structures, placing it in the path of invading viruses. Collectively our data are consistent with the prediction that viruses that fuse in the late endosomes or lysosomes are vulnerable to IFITM3's actions, while viruses that enter at the cell surface or in the early endosomes may avoid inhibition. Multiple viruses enter host cells through the late endocytic pathway, and many of these invaders are attenuated by IFN. Therefore these findings are likely to have significance for the intrinsic immune system's neutralization of a diverse array of threats.
Vyšlo v časopise:
IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry. PLoS Pathog 7(10): e32767. doi:10.1371/journal.ppat.1002337
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002337
Souhrn
To replicate, viruses must gain access to the host cell's resources. Interferon (IFN) regulates the actions of a large complement of interferon effector genes (IEGs) that prevent viral replication. The interferon inducible transmembrane protein family members, IFITM1, 2 and 3, are IEGs required for inhibition of influenza A virus, dengue virus, and West Nile virus replication in vitro. Here we report that IFN prevents emergence of viral genomes from the endosomal pathway, and that IFITM3 is both necessary and sufficient for this function. Notably, viral pseudoparticles were inhibited from transferring their contents into the host cell cytosol by IFN, and IFITM3 was required and sufficient for this action. We further demonstrate that IFN expands Rab7 and LAMP1-containing structures, and that IFITM3 overexpression is sufficient for this phenotype. Moreover, IFITM3 partially resides in late endosomal and lysosomal structures, placing it in the path of invading viruses. Collectively our data are consistent with the prediction that viruses that fuse in the late endosomes or lysosomes are vulnerable to IFITM3's actions, while viruses that enter at the cell surface or in the early endosomes may avoid inhibition. Multiple viruses enter host cells through the late endocytic pathway, and many of these invaders are attenuated by IFN. Therefore these findings are likely to have significance for the intrinsic immune system's neutralization of a diverse array of threats.
Zdroje
1. RitzwollerDPBridgesCBShetterlySYamasakiKKolczakM 2005 Effectiveness of the 2003–2004 influenza vaccine among children 6 months to 8 years of age, with 1 vs 2 doses. Pediatrics 116 153 159
2. BridgesCBThompsonWWMeltzerMIReeveGRTalamontiWJ 2000 Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284 1655 1663
3. WeinstockDMZuccottiG 2009 The evolution of influenza resistance and treatment. JAMA 301 1066 1069
4. CalfeeDPHaydenFG 1998 New approaches to influenza chemotherapy. Neuraminidase inhibitors. Drugs 56 537 553
5. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group 1998 Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352 1877 1881
6. MercerJSchelhaasMHeleniusA 2010 Virus entry by endocytosis. Annu Rev Biochem 79 803 833
7. LakadamyaliMRustMJZhuangX 2004 Endocytosis of influenza viruses. Microbes Infect 6 929 936
8. LazarowitzSGChoppinPW 1975 Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide. Virology 68 440 454
9. GartenWLinderDRottRKlenkHD 1982 The cleavage site of the hemagglutinin of fowl plague virus. Virology 122 186 190
10. MelikyanGB 2010 Driving a wedge between viral lipids blocks infection. Proc Natl Acad Sci U S A 107 17069 17070
11. CrosJFPaleseP 2003 Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res 95 3 12
12. MartinKHeleniusA 1991 Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 67 117 130
13. BuiMWillsEGHeleniusAWhittakerGR 2000 Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J Virol 74 1781 1786
14. BrassALHuangICBenitaYJohnSPKrishnanMN 2009 The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139 1243 1254
15. KarlasAMachuyNShinYPleissnerKPArtariniA 2010 Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463 818 822
16. KonigRStertzSZhouYInoueAHoffmannHH 2010 Human host factors required for influenza virus replication. Nature 463 813 817
17. ShapiraSDGat-ViksIShumBODricotAde GraceMM 2009 A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139 1255 1267
18. JiangDWeidnerJMQingMPanXBGuoH 2010 Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol 84 8332 8341
19. HuangICBaileyCCWeyerJLRadoshitzkySRBeckerMM 2011 Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog 7 e1001258
20. WeidnerJMJiangDPanXBChangJBlockTM 2010 Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J Virol 84 12646 12657
21. FriedmanRLManlySPMcMahonMKerrIMStarkGR 1984 Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 38 745 755
22. LewinARReidLEMcMahonMStarkGRKerrIM 1991 Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199 417 423
23. SiegristFEbelingMCertaU 2011 The small interferon-induced transmembrane genes and proteins. J Interferon Cytokine Res 31 183 197
24. BradburyLEKansasGSLevySEvansRLTedderTF 1992 The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules. J Immunol 149 2841 2850
25. SmithRAYoungJWeisJJWeisJH 2006 Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7 113 121
26. LangeUCAdamsDJLeeCBartonSSchneiderR 2008 Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol Cell Biol 28 4688 4696
27. LangeUCSaitouMWesternPSBartonSCSuraniMA 2003 The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev Biol 3 1
28. RopoloATomasiniRGrassoDDusettiNJCerquettiMC 2004 Cloning of IP15, a pancreatitis-induced gene whose expression inhibits cell growth. Biochem Biophys Res Commun 319 1001 1009
29. EvansSSColleaRPLeasureJALeeDB 1993 IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150 736 747
30. MoffattPGaumondMHSaloisPSellinKBessetteMC 2008 Bril: a novel bone-specific modulator of mineralization. J Bone Miner Res 23 1497 1508
31. BremROraszlan-SzovikKFoserSBohrmannBCertaU 2003 Inhibition of proliferation by 1–8 U in interferon-alpha-responsive and non-responsive cell lines. Cell Mol Life Sci 60 1235 1248
32. HanagataNLiXMoritaHTakemuraTLiJ 2010 Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J Bone Miner Metab 29 279 290
33. YountJSMoltedoBYangYYCharronGMoranTM 2010 Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 6 610 614
34. KhorRMcElroyLJWhittakerGR 2003 The ubiquitin-vacuolar protein sorting system is selectively required during entry of influenza virus into host cells. Traffic 4 857 868
35. KonigRStertzSZhouYInoueAHeinrich HoffmannH 2009 Human host factors required for influenza virus replication. Nature 463 813 817
36. LambRAKrugRM 2001 Orthomyxoviridae: The viruses and their replication.; KnipeDHowleyP Philadelphia Lippincott Williams and Wilkins
37. TobiumeMLinebergerJELundquistCAMillerMDAikenC 2003 Nef does not affect the efficiency of human immunodeficiency virus type 1 fusion with target cells. J Virol 77 10645 10650
38. TscherneDMManicassamyBGarcia-SastreA 2010 An enzymatic virus-like particle assay for sensitive detection of virus entry. J Virol Methods 163 336 343
39. HallerOKochsG 2011 Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J Interferon Cytokine Res 31 79 87
40. RonniTMatikainenSSarenevaTMelenKPirhonenJ 1997 Regulation of IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J Immunol 158 2363 2374
41. SieczkarskiSBWhittakerGR 2003 Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 4 333 343
42. LaweDCChawlaAMerithewEDumasJCarringtonW 2002 Sequential roles for phosphatidylinositol 3-phosphate and Rab5 in tethering and fusion of early endosomes via their interaction with EEA1. J Biol Chem 277 8611 8617
43. PankivSClausenTHLamarkTBrechABruunJA 2007 p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282 24131 24145
44. ShiCSKehrlJH 2010 TRAF6 and A20 regulate lysine 63-linked ubiquitination of Beclin-1 to control TLR4-induced autophagy. Sci Signal 3 ra42
45. GutierrezMGMasterSSSinghSBTaylorGAColomboMI 2004 Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119 753 766
46. DittmannJStertzSGrimmDSteelJGarcia-SastreA 2008 Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. J Virol 82 3624 3631
47. ZimmermannPManzBHallerOSchwemmleMKochsG 2011 The viral nucleoprotein determines mx sensitivity of influenza a viruses. J Virol 85 8133 8140
48. AblasserAHornungV 2011 Where, in antiviral defense, does IFIT1 fit? Nat Immunol 12 588 590
49. PichlmairALassnigCEberleCAGornaMWBaumannCL 2011 IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA. Nat Immunol 12 624 630
50. UmbachJLYenHLPoonLLCullenBR 2010 Influenza A virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. MBio 1 14 e00204 00210
51. SahaBKGrahamMYSchlessingerD 1979 Acid ribonuclease from HeLa cell lysosomes. J Biol Chem 254 5951 5957
52. RojekJMSanchezABNguyenNTde la TorreJCKunzS 2008 Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82 7677 7687
53. van der SchaarHMRustMJChenCvan der Ende-MetselaarHWilschutJ 2008 Dissecting the cell entry pathway of dengue virus by single-particle tracking in living cells. PLoS Pathog 4 e1000244
54. BernardESolignatMGayBChazalNHiggsS 2010 Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS One 5 e11479
55. MireCEWhiteJMWhittMA 2010 A spatio-temporal analysis of matrix protein and nucleocapsid trafficking during vesicular stomatitis virus uncoating. PLoS Pathog 6 e1000994
56. MeertensLBertauxCDragicT 2006 Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80 11571 11578
57. UchilPMothesW 2005 Viral entry: a detour through multivesicular bodies. Nat Cell Biol 7 641 642
58. Le BlancILuyetPPPonsVFergusonCEmansN 2005 Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol 7 653 664
59. LuJPanQRongLLiuSLLiangC 2011 The IFITM Proteins Inhibit HIV-1 Infection. J Virol 85 2126 2137
60. PertelTHausmannSMorgerDZugerSGuerraJ 2011 TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 472 361 365
61. WanXFNguyenTDavisCTSmithCBZhaoZM 2008 Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One 3 e3462
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2011 Číslo 10
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
Najčítanejšie v tomto čísle
- Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Regulates Cell Stress Response and Apoptosis
- Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- Herpesvirus Telomerase RNA (vTR) with a Mutated Template Sequence Abrogates Herpesvirus-Induced Lymphomagenesis